Adjuvant for cancer immunotherapy
US5254534A · kind A · utility
4Cited by
5References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 30, 1989 |
| Grant date | Oct 19, 1993 |
| Priority date | — |
| Expiry date | Jan 30, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An adjuvant for cancer immunotherapy with an immuno-activating agent, which comprises a colony stimulating factor as an active ingredient, can remarkably increase the antitumor effect of said immunoactivating agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.